Cell & Gene Therapy · Bioprocessing
MaxCyte: Funding & valuation
MaxCyte has $760k paid in by investors, lenders and donors.
Financials
Revenue of $33M in 2025. −14.5% on the year before. Net income −$44.6M.
$33MRevenue2025 · −14.5%
−$44.6MNet income2025 · −8.7%
$760kTotal raised
Venture - Series UnknownLatest round
Revenue by yearas filed, with the net income
Money by yearUSD, rounds and grants
Largest rounds and grants
$760k
Sources: SEC
Money
MaxCyte has $760k paid in by investors, lenders and donors.
$760kPaid in
StagePaidSignedAnnouncedSourceFiledAnnouncedPress
Money in
$760kPaid
People cost
MaxCyte filed a median H-1B wage of $118k in 2026.
Median H-1B wage by role, 2026scale to $118k
Every row links its own source. A flow two sources state counts once; a figure a source does not state reads "not stated".
